Account
Articles
01.11.2023
World Orphan Drug Congress Europe 2023 REPORT

We summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H...

Read more
Webinar
31.10.2023
NICE’s Proportionate Approach to Technology ...

Webinar: Our experts discuss NICE's proportionate approach to technology appraisals and the implicat...

Read more
Publications
25.10.2023
ISPOR Europe 2023: Can Just Three PICOs be Feasibl...

This research aims to understand if just three PICOs are feasible by analysing recent HTA assessment...

Read more
Publications
25.10.2023
ISPOR Europe 2023: How Aware Are Biotech and Pharm...

Our research aims to gauge awareness of the new EU HTA process within the pharmaceutical industry in...

Read more
Insider Insights
06.10.2023
Germany’s Health Ministry Shifts Focus to Di...

Germany is reshaping its Ministry of Health to prioritize the prevention of diseases like cancer, de...

Read more
Insider Insights
12.09.2023
New Additions to HTA International Collaboration

In a ground breaking move, the international collaboration among six prominent health technology ass...

Read more
Articles
08.08.2023
How to get payer scientific advice between now and...

Our market access experts provide an overview of how to get payer scientific advice between Septembe...

Read more
28.07.2023
Spain’s National Court Annuls Proposed Thera...

Spain's National Court recently invalidated the proposed plan for consolidating therapeutic position...

Read more
News
18.07.2023
PMA Insights: Week 29

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
02.05.2023
Unveiling the Progress of a Coordinated HTA Networ...

We explore the coordinated HTA networks involved in EUnetHTA, define the HTACG and the deliverables ...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.